Assessment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer
- 1 March 1996
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 73 (6) , 758-762
- https://doi.org/10.1038/bjc.1996.132
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Primary medical (neo-adjuvant) chemotherapy for operable breast cancerEuropean Journal Of Cancer, 1993
- Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinomaCancer, 1992
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedioneCancer Chemotherapy and Pharmacology, 1990
- NEOADJUVANT CHEMOTHERAPY IN THE COMBINED MODALITY APPROACH OF LOCALLY ADVANCED NONMETASTATIC BREAST-CANCER1987
- Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancerCancer Chemotherapy and Pharmacology, 1987
- A HUMAN TUMOUR MODELThe Lancet, 1986
- Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancerJournal of Steroid Biochemistry, 1985
- 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCERThe Lancet, 1984
- ASSESSMENT OF BIOCHEMICAL TESTS TO SCREEN FOR METASTASES IN PATIENTS WITH BREAST CANCER*1The Lancet, 1980